These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36525840)

  • 1. Structural basis of Nrf2 activation by flavonolignans from silymarin.
    Bello M
    J Mol Graph Model; 2023 Mar; 119():108393. PubMed ID: 36525840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular recognition between potential natural inhibitors of the Keap1-Nrf2 complex.
    Bello M; Morales-González JA
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):981-992. PubMed ID: 28746889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H:quinone oxidoreductase 1 in Hepa1c1c7 cells.
    Roubalová L; Dinkova-Kostova AT; Biedermann D; Křen V; Ulrichová J; Vrba J
    Fitoterapia; 2017 Jun; 119():115-120. PubMed ID: 28450126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
    Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
    Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding.
    Huerta C; Jiang X; Trevino I; Bender CF; Ferguson DA; Probst B; Swinger KK; Stoll VS; Thomas PJ; Dulubova I; Visnick M; Wigley WC
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2537-2552. PubMed ID: 27474998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Keap1-Nrf2 small-molecule inhibitors from phytochemicals based on molecular docking.
    Li M; Huang W; Jie F; Wang M; Zhong Y; Chen Q; Lu B
    Food Chem Toxicol; 2019 Nov; 133():110758. PubMed ID: 31412289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorogenic acid, quercetin, coenzyme Q10 and silymarin modulate Keap1-Nrf2/heme oxygenase-1 signaling in thioacetamide-induced acute liver toxicity.
    Hussein RM; Sawy DM; Kandeil MA; Farghaly HS
    Life Sci; 2021 Jul; 277():119460. PubMed ID: 33811899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antioxidant,
    Siddiqa A; Tajammal A; Irfan A; Munawar MA; Azam M; Basra MAR
    J Biomol Struct Dyn; 2022; 40(20):10265-10277. PubMed ID: 34176443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Binding Energy of Keap1 Interaction Motifs in the Nrf2 Antioxidant Pathway and Design of Potential High-Affinity Peptides.
    Karttunen M; Choy WY; Cino EA
    J Phys Chem B; 2018 Jun; 122(22):5851-5859. PubMed ID: 29745220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking and molecular dynamics simulation of wheat gluten-derived antioxidant peptides acting through the Keap1-Nrf2 pathway.
    Liu W; Liu R; Qin Q; Wang H; Zhang X; Meng G
    J Sci Food Agric; 2024 Oct; 104(13):8150-8161. PubMed ID: 38837798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.
    Davies TG; Wixted WE; Coyle JE; Griffiths-Jones C; Hearn K; McMenamin R; Norton D; Rich SJ; Richardson C; Saxty G; Willems HM; Woolford AJ; Cottom JE; Kou JP; Yonchuk JG; Feldser HG; Sanchez Y; Foley JP; Bolognese BJ; Logan G; Podolin PL; Yan H; Callahan JF; Heightman TD; Kerns JK
    J Med Chem; 2016 Apr; 59(8):3991-4006. PubMed ID: 27031670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2).
    Tian W; Rojo de la Vega M; Schmidlin CJ; Ooi A; Zhang DD
    J Biol Chem; 2018 Feb; 293(6):2029-2040. PubMed ID: 29255090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein-Protein Interaction.
    Zhang Y; Shi Z; Zhou Y; Xiao Q; Wang H; Peng Y
    J Med Chem; 2020 Aug; 63(15):7986-8002. PubMed ID: 32233486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications.
    Vargas-Mendoza N; Morales-González Á; Morales-Martínez M; Soriano-Ursúa MA; Delgado-Olivares L; Sandoval-Gallegos EM; Madrigal-Bujaidar E; Álvarez-González I; Madrigal-Santillán E; Morales-Gonzalez JA
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32423098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silybin and its congeners: from traditional medicine to molecular effects.
    Křen V; Valentová K
    Nat Prod Rep; 2022 Jun; 39(6):1264-1281. PubMed ID: 35510639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Protective Activity of Silymarin and its Flavonolignans.
    Vostálová J; Tinková E; Biedermann D; Kosina P; Ulrichová J; Rajnochová Svobodová A
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30875758
    [No Abstract]   [Full Text] [Related]  

  • 17. Caffeic acid prevents acetaminophen-induced liver injury by activating the Keap1-Nrf2 antioxidative defense system.
    Pang C; Zheng Z; Shi L; Sheng Y; Wei H; Wang Z; Ji L
    Free Radic Biol Med; 2016 Feb; 91():236-46. PubMed ID: 26721592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1.
    Unni S; Deshmukh P; Krishnappa G; Kommu P; Padmanabhan B
    FEBS J; 2021 Mar; 288(5):1599-1613. PubMed ID: 32672401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Activity and Structure-Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein-Protein Interaction.
    Heightman TD; Callahan JF; Chiarparin E; Coyle JE; Griffiths-Jones C; Lakdawala AS; McMenamin R; Mortenson PN; Norton D; Peakman TM; Rich SJ; Richardson C; Rumsey WL; Sanchez Y; Saxty G; Willems HMG; Wolfe L; Woolford AJ; Wu Z; Yan H; Kerns JK; Davies TG
    J Med Chem; 2019 May; 62(9):4683-4702. PubMed ID: 30973731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silychristin: Skeletal Alterations and Biological Activities.
    Biedermann D; Buchta M; Holečková V; Sedlák D; Valentová K; Cvačka J; Bednárová L; Křenková A; Kuzma M; Škuta C; Peikerová Ž; Bartůněk P; Křen V
    J Nat Prod; 2016 Dec; 79(12):3086-3092. PubMed ID: 28006905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.